Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
127,451,163
-
Total 13F shares
-
13,263,517
-
Share change
-
-111,312
-
Total reported value
-
$53,451,000
-
Price per share
-
$4.03
-
Number of holders
-
13
-
Value change
-
-$728,128
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Trevi Therapeutics, Inc. - COMMON STOCK (TRVI) as of Q3 2020
As of 30 Sep 2020,
Trevi Therapeutics, Inc. - COMMON STOCK (TRVI) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,263,517 shares.
The largest 10 holders included
NEA Management Company, LLC, TPG Group Holdings (SBS) Advisors, Inc., Omega Fund Management, LLC, FMR LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., NORTHERN TRUST CORP, and LPL Financial LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.